1. Fauci AS, HIV infections. In: Brawnwald E et al, editors. Harrison’s Principles of Internal Medicine. 16th Ed, New York: Mc-Graw Hill; 2005. P. 1076–1140.
2. Prasad HK,
Bhojwani KM,
Shenoy V,
Prasad SC. HIV manifestations in otolaryngology.
Am J Otolaryngol. 2006; 27(3): 179–85.
3. Kim MK,
Alvi A. Common head and neck manifestations of AIDS.
AIDS Patient Care STDS. 1999; 13(11): 641–4.
4. Reisacher WR,
Finn DG,
Stern J,
Zeifer B,
Cocker R. Manifestations of AIDS in the head and neck.
South Med J. 1999; 92(7): 684–97.
5.
Birchall MA,
Wight RG,
French PD,
Cockbain Z,
Smith SJ. Auditory function in patients infected with the human immunodeficiency virus.
Clin Otolaryngol Allied Sci. 1992; 17(2): 117–21.
6.
Kohan D,
Rothstein SG,
Cohen NL. Otologic disease in patients with acquired immunodeficiency syndrome.
Ann Otol Rhinol Laryngol. 1988; 97(6 Pt 1): 636–40.
7.
Rarey KE. Otologic pathophysiology in patients with human immunodeficiency virus.
Am J Otolaryngol. 1990; 11(6): 366–9.
8. Chandrasekhar SS, Conelly PE, Brahmbhatt SS, Shah CS, Kloser PC, Baredes S. Otologic and audilogic evaluation of human immunodeficiency virus-infected patients. Am J Otolaryngol. 2000; 21(1): 1–9.
9. Prasad HK, Bhojwani KM, Shenoy V, Prasad SC. HIV manifestations in otolaryngology. Am J Otolaryngol. 2006; 27(3): 179–85.
10. Jafari S, Razmpa E, Saeednejad Z, Sadrhosseini M, Paydari K, Saedi B, et al. Otolaryngological Manifestations in HIV Infected Patients, Tehran, Iran. J AIDS Clinic Res. 2012; 3: 6.
11. Bernaldez P, Morales G, Hernandez C. Chronic Suppurative Oitis Media in HIV-Infected Children. Otolaryngol Head Neck Surg. 2005; 133(2): 243–4.
12.
Cheung SW,
Lee KC,
Cha I. Orbitocerebral complications of pseudomonas sinusitis.
Laryngoscope. 1992; 102(12 Pt 1): 1385–9.
13.
Cheung SW,
Lee KC,
Cha I. Orbitocerebral complications of pseudomonas sinusitis.
Laryngoscope. 1992; 102(12 Pt 1): 1385–9.
14. Rubin j.
Hinni ML,
McCaffrey TV,
Kasperbauer JL. Early mucosal changes in experimental sinusitis.
Otolaryngol Head Neck Surg. 1992; 107(4): 537–48.
15.
Rubin JS,
Honigberg R. Sinusitis in patients with the acquired immunodeficiency syndrome.
Ear Nose Throat J. 1990; 69(7): 460–3.
16. Tami T, Wawrose SF. Disease of the nose and paranasal sinuses in the human immunodeficiency virus-infected population. Otolaryngol Clin North Am. 1992; 25: 1199–210.
17. Porter JP,
Patel AA,
Dewey CM,
Stewart MG. Prevalence of sinonasal symptoms in patients with HIV infection.
Am J Rhinol. 1999; 13(3): 203–8.
18. Gurney T, Lee K, Murr A. Contemporary issues in rhinosinusitis and HIV infection. Curr Opin Otolaryngol Head Neck Surg. 2003; 11(1): 45–8.
19. Miziara ID, Araujo Filho BC, La Cortina RC, Romano FR, Lima AS. Chronic rhinosinusitis in HIV-infected patients: radiological and clinical evaluation. Rev Bras Otorrinolaringol. 2005; 71(5): 604–8.
20. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. (Cochrane Review). In: The Cochrane Library, Issue 3, 2007. Oxford: Update Software.
21. Kalpidis CDR, Lysitsa SN, Lombardi T, Kolokotronis AE, Antoniades DZ, Samson J. Gingival involvement in a case series of patients with Acquired Immunodeficiency Syndrome-related Kaposi sarcoma. J Periodontol. 2006; 77(3): 523–32.
22. Baumgarth N, Szubin R, Dolganov GM, Watnik MR, Greenspan D, Da Costa M, et al. Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy assisted gene expression profiling. Am J Pathol. 2004; 165(3): 707–18.
23.
Smith FB,
Rajdeo H,
Panesar N,
Bhuta K,
Stahl R. Benign lymphoepithelial lesion of the parotid gland in intravenous drug users.
Arch Pathol Lab Med. 1988; 112(7): 742–5.
24.
Staskus KA,
Zhong W,
Gebhard K,
Herndier B,
Wang H,
Renne R,
Beneke J,
Pudney J,
Anderson
DJ,
Ganem D,
Haase AT. Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.
J Virol. 1997; 71(1): 715–9.
25. Miziara ID, Weber R. Oral candidosis and oral hairy leukoplakia a predictors of HAART failure in Brazilian HIV-infected patients. Oral Dis 2006; 12: 402–7.
26. Ranganathan K, Hemalatha R. Oral lesions in HIV infection in developing countries: an overview. Adv Dent Res. 2006; 19(1): 63– 8.
27. Reznik DA. Oral manifestations of HIV disease. Top HIV Med. 2005–2006;13(5):143–8.
28. Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res. 2006; 19: 57–62.
29. Miziara ID, Araujo Filho BC, Weber R. AIDS e estomatite aftóide recidivante. Braz J Otorhinolaringol. 2005; 71(4): 517–20.
30.
Birchall MA,
Horner PD,
Stafford ND. Changing patterns of HIV infection in otolaryngology.
ClinOtolaryngol Allied Sci. 1994; 19(6): 473–7.
31. Gurney T, Murr A. Otolaryngologic manifestations of human immunodeficiency virus infection. Otolaryngol Clin N Am. 2003; 36: 607–24.
32. Mandel L, Surattanont F. Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence. Oral Surg Oral Med Oral Pathol Oral Raiol Endod. 2002; 94(4): 454–9.
33. Steele NP, Sampogna D, Sessions RB. Kaposi´s Sarcoma of an Intraparotid Lymph Node Leading to a Diagnosis of HIV. Laryngoscope. 2005; 115: 861–3.